Differences between the effects of cromakalim and nifedipine on agonist‐induced responses in rabbit aorta
Authors:
Open Access
- 1 February 1991
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 102 (2) , 337-344
Abstract
The effects of cromakalim on endothelium‐denuded rabbit aortic strips were compared with those of the calcium (Ca2+) entry blocking agent, nifedipine. Pre‐incubation with cromakalim or nifedipine had no significant effect on the initial phasic component of noradrenaline (NA)‐induced responses. Cromakalim (0.3–10 μm), but not nifedipine, inhibited the maintained tonic contractions produced by NA. The effects of cromakalim were antagonized by raising extracellular [K+] or by glibenclamide. Nifedipine inhibited contractions produced by KCl (40 mm) whereas cromakalim had no effect. In Ca2+‐free physiological salt solution (PSS), cromakalim produced a significant inhibition of both the refilling of and the release of Ca2+ from NA‐releasable Ca2+ stores, whereas nifedipine was ineffective. In tissues preloaded with 42K+ cromakalim (0.3–10 μm) produced a concentration‐dependent increase in the 42K+ efflux rate coefficient. NA (0.3 μm) also produced an increase in the rate of efflux of 42K+, an effect which was not antagonized by nifedipine (0.3 μm). When microelectrodes were used, cromakalim (1–10 μm) produced a maintained concentration‐dependent membrane hyperpolarization. However, low concentrations of cromakalim (2+ channels. Instead, cromakalim may exert a direct inhibitory action on Ca2+ uptake into and release from Ca2+ stores and additionally inhibit the pathway through which Ca2+ passes from the extracellular fluid to intracellular Ca2+ stores.Keywords
This publication has 29 references indexed in Scilit:
- Hyperpolarizing Vasodilators Activate ATP-sensitive K + Channels in Arterial Smooth MuscleScience, 1989
- Rabbit aorta: electrical properties and agonist-induced depolarizationEuropean Journal of Pharmacology, 1989
- Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activatorBiochemical Pharmacology, 1987
- Dissociation of actions of BRL 34915 in the rat portal veinEuropean Journal of Pharmacology, 1987
- BRL 34915, A Novel Antihypertensive Agent: Comparison of Effects on Blood Pressure and Other Haemodynamic Parameters with Those of Nifedipine in Animal ModelsJournal of Cardiovascular Pharmacology, 1987
- Two kinds of calcium channels in canine atrial cells. Differences in kinetics, selectivity, and pharmacology.Journal of General Physiology, 1985
- Theoretical Bases for Vascular Selectivity of Ca2+ AntagonistsJournal of Cardiovascular Pharmacology, 1984
- Differential calcium dependence of contractile responses and 86Rb efflux from the rabbit aorta induced by vasoactive stimuliJournal of Cellular Physiology, 1983
- SARCOPLASMIC RETICULUM AND EXCITATION-CONTRACTION COUPLING IN MAMMALIAN SMOOTH MUSCLESJournal of Cell Biology, 1972
- Excitation-Contraction Coupling in Rabbit Aorta Studied by the Lanthanum Method for Measuring Cellular Calcium InfluxCirculation Research, 1972